Top

BMC Cancer

Published in:

Open Access 01-12-2010 | Technical advance

Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients

Published in: BMC Cancer | Issue 1/2010

Title: Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients
Publication date: 01-12-2010
Published in: BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/1471-2407-10-242

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2010

The 4q27 locus and prostate cancer risk

Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease

Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivotumor growth

Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma

Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer

Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population

Keynote webinar | Spotlight on antibody–drug conjugates in cancer